Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Executive or director change
  2. 8-K Event Other events
  3. 8-K Event Other events
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Material agreement · Acquisition or sale completed · Other events
  7. 8-K Event Other events
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. 8-K Event Other events
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 4 Open-market sale 10% owner sold 1,538,062 shares at an average $5.31 ($8,168,547)
  15. SC 13D/A Stake Beneficial Ownership Report
  16. 8-K Event Other events
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 30 · 584 filings